{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:59:50Z","timestamp":1780498790520,"version":"3.54.1"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The purpose of this study was to evaluate if long-term (6 months) treatment with lasofoxifene (LAS), a new selective estrogen receptor modulator (SERM), can protect against age-related changes in bone mass and bone strength in intact aged male rats. Sprague-Dawley male rats at 15 months of age were treated (daily oral gavage) with either vehicle (n = 12) or LAS at 0.01 mg\/kg per day (n = 12) or 0.1 mg\/kg per day (n = 11) for 6 months. A group of 15 rats was necropsied at 15 months of age and served as basal controls. No significant change was found in body weight between basal and vehicle controls. However, an age-related increase in fat body mass (+42%) and decrease in lean body mass (\u22128.5%) was observed in controls. Compared with vehicle controls, LAS at both doses significantly decreased body weight and fat body mass but did not affect lean body mass. No significant difference was found in prostate wet weight among all groups. Total serum cholesterol was significantly decreased in all LAS-treated rats compared with both the basal and the vehicle controls. Both doses of LAS treatment completely prevented the age-related increase in serum osteocalcin. Peripheral quantitative computerized tomography (pQCT) analysis at the distal femoral metaphysis indicated that the age-related decrease in total density, trabecular density, and cortical thickness was completely prevented by treatment with LAS at 0.01 mg\/kg per day or 0.1 mg\/kg per day. Histomorphometric analysis of proximal tibial cancellous bone showed an age-related decrease in trabecular bone volume (TBV; \u221246%), trabecular number (Tb.N), wall thickness (W.Th), mineral apposition rate, and bone formation rate-tissue area referent. Moreover, an age-related increase in trabecular separation (Tb.Sp) and eroded surface was observed. LAS at 0.01 mg\/kg per day or 0.1 mg\/kg per day completely prevented these age-related changes in bone mass, bone structure, and bone turnover. Similarly, the age-related decrease in TBV and trabecular thickness (Tb.Th) and the age-related increase in osteoclast number (Oc.N) and osteoclast surface (Oc.S) in the third lumbar vertebral cancellous bone were completely prevented by treatment with LAS at both doses. Further, LAS at both doses completely prevented the age-related decrease in ultimate strength (\u221247%) and stiffness (\u221237%) of the fifth lumbar vertebral body. These results show that treatment with LAS for 6 months in male rats completely prevents the age-related decreases in bone mass and bone strength by inhibiting the increased bone resorption and bone turnover associated with aging. Further, LAS reduced total serum cholesterol and did not affect the prostate weight in these rats. Our data support the potential use of a SERM for protecting against the age-related changes in bone and serum cholesterol in elderly men.<\/jats:p>","DOI":"10.1359\/jbmr.2001.16.4.765","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T03:39:48Z","timestamp":1146109188000},"page":"765-773","source":"Crossref","is-referenced-by-count":67,"title":["Lasofoxifene (CP-336,156) Protects Against the Age-Related Changes in Bone Mass, Bone Strength, and Total Serum Cholesterol in Intact Aged Male Rats"],"prefix":"10.1093","volume":"16","author":[{"given":"Hua Zhu","family":"Ke","sequence":"first","affiliation":[{"name":"Osteoporosis Research, Department of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Incorporated, Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Qi","sequence":"additional","affiliation":[{"name":"Osteoporosis Research, Department of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Incorporated, Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Chidsey-Frink","sequence":"additional","affiliation":[{"name":"Osteoporosis Research, Department of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Incorporated, Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Todd","family":"Crawford","sequence":"additional","affiliation":[{"name":"Osteoporosis Research, Department of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Incorporated, Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Osteoporosis Research, Department of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Incorporated, Groton, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"2024020714132460800_bib1","first-page":"1","volume-title":"Osteoporosis in Men: The Effects of Gender on Skeletal Health","author":"Melton","year":"1999"},{"key":"2024020714132460800_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","article-title":"Hip fractures in the elderly: A world-wide projection","volume":"2","author":"Cooper","year":"1992","journal-title":"Osteoporos Int"},{"key":"2024020714132460800_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/B978-012528640-4\/50018-6","volume-title":"Osteoporosis in Men: The Effects of Gender on Skeletal Health","author":"Nguyen","year":"1999"},{"key":"2024020714132460800_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/B978-012528640-4\/50014-9","volume-title":"Osteoporosis in Men: The Effects of Gender on Skeletal Health","author":"Orwoll","year":"1999"},{"key":"2024020714132460800_bib5","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1172\/JCI119701","article-title":"Sex steroids and bone mass in older men","volume":"100","author":"Slemenda","year":"1997","journal-title":"J Clin Invest"},{"key":"2024020714132460800_bib6","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1359\/jbmr.1997.12.11.1833","article-title":"Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study","volume":"12","author":"Greendale","year":"1997","journal-title":"J Bone Miner Res"},{"key":"2024020714132460800_bib7","first-page":"2266","article-title":"Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen","volume":"83","author":"Khosla","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714132460800_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"2024020714132460800_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1056\/NEJM199410203311604","article-title":"Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man","volume":"331","author":"Smith","year":"1994","journal-title":"N Engl J Med"},{"key":"2024020714132460800_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S8756-3282(00)00246-5","article-title":"Preliminary evidence for impaired estrogen receptor-\u03b1 protein expression in osteoblast and osteocytes from men with idiopathic osteoporosis","volume":"26","author":"Braidman","year":"2000","journal-title":"Bone"},{"key":"2024020714132460800_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01771666","article-title":"A pharmacological review of raloxifene","volume":"14","author":"Bryant","year":"1996","journal-title":"J Bone Miner Metab"},{"key":"2024020714132460800_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY 139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats","volume":"93","author":"Black","year":"1994","journal-title":"J Clin Invest"},{"key":"2024020714132460800_bib13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1210\/endo.135.5.7956922","article-title":"Raloxifene preserves bone strength and bone mass in ovariectomized rats","volume":"135","author":"Turner","year":"1994","journal-title":"Endocrinology"},{"key":"2024020714132460800_bib14","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1210\/endo.136.6.7750465","article-title":"Droloxifene, a new estrogen antagonist\/agonist, prevents bone loss in ovariectomized rats","volume":"136","author":"Ke","year":"1995","journal-title":"Endocrinology"},{"key":"2024020714132460800_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S8756-3282(96)00313-4","article-title":"Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model","volume":"20","author":"Ke","year":"1997","journal-title":"Bone"},{"key":"2024020714132460800_bib16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentration, and uterine endometrium in postmenopausal women","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"2024020714132460800_bib17","first-page":"418","article-title":"Selective estrogen receptor modulators: Clinical spectrum","volume":"20","author":"Cosman","year":"1999","journal-title":"Endocr Rev"},{"key":"2024020714132460800_bib18","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effects of raloxifene on risk of breast cancer in postmenopausal women: Results from the MORE randomized trial","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"2024020714132460800_bib19","first-page":"1681","article-title":"Tamoxifen for the prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"87","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2024020714132460800_bib20","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/endo.139.4.5902","article-title":"Effects of CP-336,156, a new, nonsteroidal estrogen agonist\/antagonist, on bone, serum cholesterol, uterus, and body composition in rat models","volume":"139","author":"Ke","year":"1998","journal-title":"Endocrinology"},{"key":"2024020714132460800_bib21","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/endo.141.4.7408","article-title":"Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat","volume":"141","author":"Ke","year":"2000","journal-title":"Endocrinology"},{"key":"2024020714132460800_bib22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02058664","article-title":"Tetracycline-based histologic analysis of bone remodeling","volume":"3","author":"Frost","year":"1969","journal-title":"Calcif Tissue Int"},{"key":"2024020714132460800_bib23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S8756-3282(98)00076-3","article-title":"Comparision of three-point bending test and peripheral quantitative computed tomography analysis in the evaluation of the strength of mouse femur and tibia","volume":"23","author":"Jamsa","year":"1998","journal-title":"Bone"},{"key":"2024020714132460800_bib24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1172\/JCI6730","article-title":"Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ER\u03b2\u2212\/\u2212 mice","volume":"104","author":"Windahl","year":"1999","journal-title":"J Clin Invest"},{"key":"2024020714132460800_bib25","first-page":"13","volume-title":"Bone Histomorphometry: Techniques and Interpretation","author":"Baron","year":"1983"},{"key":"2024020714132460800_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: Standardization of nomenclature, symbols, and units","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024020714132460800_bib27","first-page":"87","volume-title":"Handbook of Bone Morphology","author":"Jee","year":"1997"},{"key":"2024020714132460800_bib28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1210\/endo.134.5.8156913","article-title":"The effect on vertebral bone mass and strength of long term treatment with antiresorptive agents, human PTH (1\u201338), and combination therapy, assessed in aged ovariectomized rats","volume":"134","author":"Mosekilde","year":"1994","journal-title":"Endocrinology"},{"key":"2024020714132460800_bib29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S8756-3282(98)00102-1","article-title":"Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia","volume":"23","author":"Ke","year":"1998","journal-title":"Bone"},{"key":"2024020714132460800_bib30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: A tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"key":"2024020714132460800_bib31","first-page":"299","volume-title":"Fundamentals of Biostatistics","author":"Rosner","year":"1995","edition":"4th Ed."},{"key":"2024020714132460800_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/B978-012528640-4\/50004-6","volume-title":"Osteoporosis in Men: The Effects of Gender on Skeletal Health","author":"Anderson","year":"1999"},{"key":"2024020714132460800_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0021-9150(98)00022-7","article-title":"Oral estrogen improves serum lipid, homocysteine and fibrinolysis in elderly men","volume":"137","author":"Giri","year":"1998","journal-title":"Atherosclerosis"},{"key":"2024020714132460800_bib34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S8756-3282(98)00131-8","article-title":"Action of androgen versus estrogen in male skeletal homeostasis","volume":"23","author":"Vanderschueren","year":"1998","journal-title":"Bone"},{"key":"2024020714132460800_bib35","first-page":"3689","article-title":"Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens","volume":"80","author":"Morishima","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2024020714132460800_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","article-title":"Increased bone mass as a results of estrogen therapy in a man with aromatase deficiency","volume":"339","author":"Bilezikian","year":"1998","journal-title":"N Engl J Med"},{"key":"2024020714132460800_bib37","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1073\/pnas.97.10.5474","article-title":"Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice","volume":"97","author":"Vidal","year":"2000","journal-title":"PNAS"},{"key":"2024020714132460800_bib38","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jbmr.5650100319","article-title":"Relations between histologic indices of bone formation: Implication for the pathogenesis of spinal osteoporosis","volume":"10","author":"Parfitt","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024020714132460800_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jbmr.5650090310","article-title":"Evidence for a diminished maturation of preosteoblasts into osteoblasts during aging in rats: An ultrastructural analysis","volume":"9","author":"Roholl","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024020714132460800_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/8756-3282(92)90074-7","article-title":"Age-dependent morphometric alterations in the distal femora of male and female rats","volume":"13","author":"Sontag","year":"1992","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1359%2Fjbmr.2001.16.4.765","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/16\/4\/765\/56606864\/5650160419.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/16\/4\/765\/56606864\/5650160419.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:02:43Z","timestamp":1710342163000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/16\/4\/765-773\/7516013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,1]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,12,2]]},"published-print":{"date-parts":[[2001,4,1]]}},"URL":"https:\/\/doi.org\/10.1359\/jbmr.2001.16.4.765","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2001,4,1]]},"published":{"date-parts":[[2001,4,1]]}}}